The global medical nutrition market is estimated to be valued at USD 13.91 Bn in 2024 and is expected to exhibit a CAGR of 5.4% during the forecast period (2024-2031). The medical nutrition market has seen significant growth over the past decade driven by the increasing prevalence of chronic diseases and growing elderly population worldwide who are more susceptible to nutritional deficiencies. Various factors, such as the rising consumer awareness about nutrition, innovative new product launches catering to specific dietary requirements, and promotion of healthy diets by governments and health organizations have also contributed to the rising demand. It is expected that the market will continue expanding at a steady pace through 2030 as the focus on preventive healthcare increases and more individuals seek medically-tailored nutritional solutions.

Market Dynamics:

The global medical nutrition market is driven by the growing geriatric population, rising chronic disease burden, and increasing health consciousness among consumers. However, strict regulatory frameworks and reimbursement policies pose challenges to market players. Major opportunities include innovative product development, expansion into untapped emerging markets, and promoting nutrition therapy as an important component of chronic disease management.

Key Features of the Study:

• This report provides an in-depth analysis of the global medical nutrition market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global medical nutrition market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study Abbott, Danone S.A., Baxter, Nestlé, GSK plc., Sun Pharmaceutical Industries Ltd., Sanofi, DSM, BASF SE, Fresenius SE & Co. KGaA, Leprino Foods Company, Kate Farms, and Guardion Health Sciences, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global medical nutrition market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical nutrition market.

Detailed Segmentation-

• Nutrition Type:
  • Proteins
  • Carbohydrates
  • Multivitamins & Antioxidants
  • Amino Acids
  • Fibers
  • Minerals
  • Others
• Indication:
  • Diabetes
  • Cancer
  • Gastrointestinal Diseases
  • Metabolic Syndromes
  • Others
• Patient Type:
  • Infant Nutrition
  • Adult Nutrition
  • Geriatric Nutrition
• Route of Administration:
  • Oral
  • Enteral
  • Parenteral
• End User:
  • Hospitals
  • Home Care Settings
  • Long Term Care
  • Ambulatory Surgical Centers  
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Abbott
  • Danone S.A.
  • Baxter
  • Nestlé
  • GSK plc.
  • Sun Pharmaceutical Industries Ltd.
  • Sanofi
  • DSM
  • BASF SE
  • Fresenius SE & Co. KGaA
  • Leprino Foods Company
  • Kate Farms
  • Guardion Health Sciences, Inc.